Itoh Naohiro, Motokura Kouji, Kumakura Akira, Hata Daisuke, Hata Atsuko
Department of Pediatrics, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka City, Osaka, Japan.
Pediatr Int. 2017 Oct;59(10):1116-1118. doi: 10.1111/ped.13362.
We encountered two cases of Herpes zoster (HZ) meningitis, a rarely occurring complication of HZ, in previously healthy children. One patient treated with i.v. acyclovir (ACV, 31 mg/kg/day) did not recover. His symptoms were relieved somewhat by increased ACV dosage, but it caused transient renal dysfunction. Another patient treated with i.v. ACV (30 mg/kg/day) recovered. Treatment for HZ meningitis in immunocompetent children has not been established. In a literature review, 80% of 20 patients were treated with the usual dose of ACV 15-30 mg/kg/day. The present cases suggest that a high dosage of ACV up to 60 mg/kg/day should be considered (while monitoring for side-effects) unless symptoms improve. In the review, one of every three vaccine-strain Varicella zoster virus (VZV) cases was severe, whereas the present cases resulted from wild type. Further investigations must examine different clinical characteristics of HZ meningitis caused by wild-type and vaccine-strain VZV.
我们在既往健康的儿童中遇到了两例带状疱疹(HZ)脑膜炎,这是一种罕见的HZ并发症。一名接受静脉注射阿昔洛韦(ACV,31mg/kg/天)治疗的患者未康复。增加ACV剂量后其症状有所缓解,但导致了短暂的肾功能不全。另一名接受静脉注射ACV(30mg/kg/天)治疗的患者康复了。免疫功能正常儿童的HZ脑膜炎治疗方法尚未确立。在一项文献综述中,20例患者中有80%接受了15 - 30mg/kg/天的常规剂量ACV治疗。目前的病例表明,除非症状改善,否则应考虑使用高达60mg/kg/天的高剂量ACV(同时监测副作用)。在该综述中,每三例疫苗株水痘带状疱疹病毒(VZV)病例中就有一例病情严重,而目前的病例是由野生型引起的。进一步的研究必须考察由野生型和疫苗株VZV引起的HZ脑膜炎的不同临床特征。